BeiGene | BiotechTV

top of page

Search

BeiGene CEO John Oyler discusses the breadth of the company's pipeline at #ASCO24

Jun 2

BeiGene CEO John Oyler discusses the breadth of the company's pipeline at #ASCO24

John Oyler discusses the company's marketed BTK and PD-1 therapies, and highlights a handful of programs and targets in the pipeline like...

John Oyler shares an update on BeiGene during San Francisco Healthcare Week

Jan 10

John Oyler shares an update on BeiGene during San Francisco Healthcare Week

John Oyler discusses BeiGene's BTK, PD1, and other programs, and talks about the company's cost structure.

BeiGene on BTK Inhibitors and the Inflation Reduction Act.

Jan 10, 2023

BeiGene on BTK Inhibitors and the Inflation Reduction Act.

John Oyler discusses BeiGene's BTK inhibitor Brukinsa and cautions about the Inflation Reduction Act.

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsors

NYSE_logo_large_no reg_378x197 (1).png

Learn more about our sponsors

Sponsor Spotlight

Klein Hersh is a precision executive search firm with over 25 years of proven success partnering with clients to deliver the visionary leaders shaping the future of life sciences and healthcare. We believe that the innovation behind a healthier world starts with bringing the best and brightest minds together. Our experienced team of dedicated experts is deeply immersed in every facet of pharma, biotech, and healthcare, and has developed trusted relationships with far-reaching talent networks.

Visit Klein Hersh

bottom of page